YD Bio (YDESW) Other Accumulated Expenses (2024 - 2026)
YD Bio's (YDESW) quarterly Other Accumulated Expenses came in at $358864.0 in Q2 2026, up 462.99% year-over-year from $63743.0 in Q2 2025, and down 54.32% quarter-over-quarter from $785665.0 in Q4 2025.
Analysis
YD Bio (YDESW) Other Accumulated Expenses (2024 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Other Accumulated Expenses for 3 consecutive years, with $358864.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Accumulated Expenses rose 462.99% year-over-year to $358864.0 in Q2 2026; TTM through Jun 2026 was $358864.0, a 462.99% increase from a year earlier, with the FY2025 full-year figure at $785665.0, up 2009.0% from the prior year.
- Other Accumulated Expenses was $358864.0 for Q2 2026 at YD Bio, down from $785665.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $785665.0 in Q4 2025 and troughed at $37253.0 in Q4 2024.
- A 3-year average of $311381.2 and a median of $211303.5 in 2025 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses soared 2009.0% in 2025 and jumped 462.99% in 2026, its largest moves.
- Over 3 years, Other Accumulated Expenses stood at $37253.0 in 2024, then soared by 2009.0% to $785665.0 in 2025, then sank by 54.32% to $358864.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $358864.0 (Q2 2026), $785665.0 (Q4 2025), and $63743.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 358,864.00 |
| Dec 31, 2025 | 785,665.00 |
| Jun 30, 2025 | 63,743.00 |
| Dec 31, 2024 | 37,253.00 |